2018-07-31 17:00 | | CMS Releases Proposed 2019 Medicare Fee Schedule, Collapses Some E/M Codes Into Single Rate |
2018-07-30 15:30 | | Midlife Orthostatic Hypotension May Increase Risk of Dementia, Stroke |
2018-07-27 15:30 | | Maternal Prenatal Depression, Anxiety Affects Child Development, Particularly in Poorer Families |
2018-07-26 12:30 | | Escitalopram May Improve Long-Term Outcomes After Heart Attack |
2018-07-25 16:30 | | APA Awarded $7.1M for Fellowship Aimed at Improving Mental Health Care for Underserved Populations |
2018-07-24 19:00 | | APA Joins in Urging House, Senate to Investigate Treatment of Immigrant Children |
2018-07-20 13:30 | | Low-Dose Ketamine Offers Effective Alternative to Opioids in Treatment of Acute Pain, Meta-Analysis Suggests |
2018-07-19 16:00 | | APA Joins With Research!America to Offer Scientists Grants to Engage Candidates During Midterm Elections |
2018-07-18 17:00 | | Reducing EMR Default Settings for Opioids Prescribed After Surgery May Help Address Opioid Epidemic |
2018-07-17 16:00 | | Study Finds 60% of Privately Insured Youth With PTSD Receive Psychotherapy |
2018-07-16 15:00 | | Report Reveals Patterns of Potentially Unsafe Use of Zolpidem |
2018-07-13 16:00 | | Avatar-Guided Virtual Reality Therapy Found to Reduce Fear of Heights |
2018-07-12 18:30 | | APA Awarded $14.2 Million Grant to Improve Treatment for Serious Mental Illness |
2018-07-12 10:30 | | Highlights From APA’s 2018 Annual Meeting: Issue #3 |
2018-07-11 17:00 | | ED-Administered Safety Planning Intervention Reduces Suicidal Behaviors |
2018-07-10 16:00 | | Opioid Prescribing for Teens Exceeded CDC 2016 Guidelines for Adults |
2018-07-09 16:00 | | Rates of Routine Depression Screening on Rise but Still Low |
2018-07-06 16:00 | | Active Participation in Health Care Governance Said to Combat Physician Burnout |
2018-07-05 11:00 | | Prenatal Exposure to Folic Acid Appears to Promote Healthy Brain Development |
2018-07-03 15:30 | | Retinal Nerve Fiber Thickness May Offer Clues to Predict Cognitive Decline |
2018-07-02 13:00 | | FDA Approves Aristada Initio to Allow Immediate Initiation of the Long-Acting Atypical Antipsychotic |